44 related articles for article (PubMed ID: 7614252)
1. The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal Ganglia of acutely infected mice.
Peng W; Henderson G; Inman M; BenMohamed L; Perng GC; Wechsler SL; Jones C
J Virol; 2005 May; 79(10):6162-71. PubMed ID: 15858001
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus 1 regulates β-catenin expression in TG neurons during the latency-reactivation cycle.
Harrison KS; Zhu L; Thunuguntla P; Jones C
PLoS One; 2020; 15(3):e0230870. PubMed ID: 32226020
[TBL] [Abstract][Full Text] [Related]
3. Inducible cyclic AMP early repressor produces reactivation of latent herpes simplex virus type 1 in neurons in vitro.
Colgin MA; Smith RL; Wilcox CL
J Virol; 2001 Mar; 75(6):2912-20. PubMed ID: 11222716
[TBL] [Abstract][Full Text] [Related]
4. The anti-apoptotic function of HSV-1 LAT in neuronal cell cultures but not its function during reactivation correlates with expression of two small non-coding RNAs, sncRNA1&2.
Oh JJ; Jaggi U; Tormanen K; Wang S; Hirose S; Ghiasi H
PLoS Pathog; 2024 Jun; 20(6):e1012307. PubMed ID: 38857310
[TBL] [Abstract][Full Text] [Related]
5. A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.
Proença JT; Coleman HM; Connor V; Winton DJ; Efstathiou S
J Gen Virol; 2008 Dec; 89(Pt 12):2965-2974. PubMed ID: 19008381
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production.
Pesola JM; Zhu J; Knipe DM; Coen DM
J Virol; 2005 Dec; 79(23):14516-25. PubMed ID: 16282451
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.
Goins WF; Lee KA; Cavalcoli JD; O'Malley ME; DeKosky ST; Fink DJ; Glorioso JC
J Virol; 1999 Jan; 73(1):519-32. PubMed ID: 9847358
[TBL] [Abstract][Full Text] [Related]
8. PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.
Thackray AM; Bujdoso R
J Virol; 2002 Mar; 76(5):2498-509. PubMed ID: 11836428
[TBL] [Abstract][Full Text] [Related]
9. Examination of neuro-inflammation and senescence in brainstem of aged mice latently infected with human alphaherpesvirus 1 (HSV-1).
Monteiro R; Kumar Sivasubramanian M; Harrison KS; Plakkot B; Sadeghi H; Subramanian M; Jones C
Virus Res; 2024 Jun; 347():199420. PubMed ID: 38880336
[TBL] [Abstract][Full Text] [Related]
10. Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice.
Liu W; Griffin G; Clarke T; Parente MK; Valentino RJ; Wolfe JH; Fraser NW
Mol Ther Methods Clin Dev; 2015; 2():14059. PubMed ID: 26052529
[TBL] [Abstract][Full Text] [Related]
11. Construction of a herpes simplex virus type 1 mutant with only a three-nucleotide change in the branchpoint region of the latency-associated transcript (LAT) and the stability of its two-kilobase LAT intron.
Ng AK; Block TM; Aiamkitsumrit B; Wang M; Clementi E; Wu TT; Taylor JM; Su YH
J Virol; 2004 Nov; 78(22):12097-106. PubMed ID: 15507596
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus-based vectors.
Lachmann R
Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
[TBL] [Abstract][Full Text] [Related]
13. Infection and establishment of latency in the dog brain after direct inoculation of a nonpathogenic strain of herpes simplex virus-1.
Springer SL; Vite CH; Polesky AC; Kesari S; Fraser NW; Wolfe JH
J Neurovirol; 2001 Apr; 7(2):149-54. PubMed ID: 11517387
[TBL] [Abstract][Full Text] [Related]
14. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency.
Lokensgard JR; Berthomme H; Feldman LT
J Virol; 1997 Sep; 71(9):6714-9. PubMed ID: 9261395
[TBL] [Abstract][Full Text] [Related]
15. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
Lachmann RH; Efstathiou S
J Virol; 1997 Apr; 71(4):3197-207. PubMed ID: 9060683
[TBL] [Abstract][Full Text] [Related]
16. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
Deshmane SL; Valyi-Nagy T; Block T; Maggioncalda J; Wolfe JH; Dillner A; Fraser NW
Gene Ther; 1995 May; 2(3):209-17. PubMed ID: 7614252
[TBL] [Abstract][Full Text] [Related]
17. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
18. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
[TBL] [Abstract][Full Text] [Related]
19. beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia.
Huang QS; Valyi-Nagy T; Kesari S; Fraser NW
Gene Ther; 1997 Aug; 4(8):797-807. PubMed ID: 9338008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
